Familial Chylomicronemia Syndrome (FCS) Waylivra (Volanesorsen) approved as first and only Therapy for FCS

[Anonymous]

VISCERAL MEDICINE, 2019; 35 (4): 277

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索